Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra Insiders buying today?

<< Previous

Bullboard Posts

Next >>

Post by Davesnothereon Sep 07, 2022 8:31am

189 Views

Post# 34946011

Tetra Insiders buying today?

We could see some insider buying now that the partnership/ collaboration with Cellvera is public information. That would make a statement. Btw , I saw a post on Facebook that indicates FB did not approve of our news release because we will now be competing directly with Pfizer. Maybe Pfizer has paid to have influence with FB. Pfizer trying to shutdown the competition! WOW are in the big leagues now $$$.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?